United Arab Emirates planning ranges
CAR-T Cell Therapy cost in United Arab Emirates$286,000–$468,000
Get a Personalized Cost EstimateCAR-T Cell Therapy in United Arab Emirates plans at $286,000–$468,000, an indicative band scaled from our India catalog figure rather than a hospital tariff. Typical stay is regimen- and cycle-dependent, and the market sits at ≈2.9× India.
Regional premium private care. Travel may be shorter for Gulf families; pharmacy, infusion, specialist and monitoring charges may still be billed separately.
CAR-T cell therapy collects a patient's T cells, genetically engineers them to recognise a cancer target, expands them, then returns them after lymphodepleting treatment.
The pathway includes apheresis, off-site or on-site manufacturing, possible bridging therapy, lymphodepletion, a single cell infusion and close post-infusion monitoring.
Frequent clinical observations and laboratory tests follow infusion. Fever, low blood pressure, breathing difficulty, confusion or seizures require urgent protocol-based assessment.
The same assumption priced in each market. Read United Arab Emirates against the rest of the row rather than on its own, and confirm any figure with a written quotation from a named hospital in that country.
Swipe to compare destinations →
| Country | Approximate cost | Relative cost position | Important cost considerations |
|---|---|---|---|
| India | $80,000–$180,000 | Baseline | GAF catalog planning range. The stored India figure is a comparison band. A named medical oncologist must review pathology, stage, biomarkers, dose and cycle assumptions before a hospital issues an itemized estimate. |
| Turkey | $143,000–$234,000Indicative planning estimate* | ≈1.4× India | Private international oncology market. Compare the exact medicines, dose basis, number of cycles, laboratory monitoring and supportive drugs rather than a general cancer package. |
| Thailand | $169,000–$286,000Indicative planning estimate* | ≈1.8× India | Private international hospitals. International desks may coordinate care, but medicine acquisition, biomarker testing, day-care fees and lodging between cycles need written confirmation. |
| United Arab Emirates | $286,000–$468,000Indicative planning estimate* | ≈2.9× India | Regional premium private care. Travel may be shorter for Gulf families; pharmacy, infusion, specialist and monitoring charges may still be billed separately. |
| Singapore | $364,000–$624,000Indicative planning estimate* | ≈3.8× India | High-cost specialist private care. Ask for a self-pay estimate tied to drug names, vial use, dose, cycles and biomarker assumptions rather than a broad medical-oncology label. |
| Germany | $325,000–$585,000Indicative planning estimate* | ≈3.5× India | European specialist oncology care. International access, medicine reimbursement, professional billing and follow-up arrangements vary by centre and patient status. |
| United Kingdom | $286,000–$520,000Indicative planning estimate* | ≈3.1× India | Private self-pay for many visitors. Overseas patients should confirm eligibility, private pharmacy pricing, infusion fees and who manages toxicity after they return home. |
| United States | $400,000–$550,000 | ≈3.7× India | Stored self-pay reference. Hospital, oncologist, laboratory, imaging and drug bills may come from different entities. $400,000–$550,000 is a catalog comparison band, not one bundled quotation. |
*Figures other than India and the United States are modelled planning estimates scaled from the India catalog band, not hospital quotations. All figures are planning information. Cancer type, stage, regimen, drug origin, dose, cycles, tests, supportive care, hospital terms and currency can change the final amount; no row predicts outcome.
Dr. Shabnam Choudhary, BDS, is a dental professional who graduated from Al-Ameen Medical College, Bijapur, Karnataka. She contributes to the curation and development of medically informative healthcare content, helping ensure that information is structured clearly and presented in a patient-friendly manner.
Content Curator
BDS
Al-Ameen Medical College, Bijapur, Karnataka
Rajiv Gandhi University of Health Sciences (RGUHS), Bengaluru
Dr. Saffiyyah Chaudhary, BDS, is a dental professional who graduated from Al-Ameen Medical College, Bijapur, Karnataka. She provides medical review of healthcare content to help ensure that clinical information is accurate, understandable, and appropriately presented for patients and their families.
Medically Reviewed By
BDS
Al-Ameen Medical College, Bijapur, Karnataka
Rajiv Gandhi University of Health Sciences (RGUHS), Bengaluru
Patient stories
Google reviews
5.0 from 10 reviews on the GAF Healthcare Pvt Ltd Google listing.
★★★★★
Initially I was very hesitant what to do, where to go for the treatment of my father who was suffering with prostate cancer. Thanks to google, I came into touch with Gaf Healthcare. They have arranged everything, starting from treatment plan, video consultation, airport pickup, to surgery and following up. My father was operated in Sahyadri Pune, robotic prostatectomy was done. Now he is fine.
★★★★★
The hospitality was at its point. I appreciate the great service I got from the team. Being away from Home and get the feeling like you are at home is what Gaf is doing. Thank you once more, this have lifetime memories in my life.
★★★★★
Wonderful experience with Gaf Healthcare. I was quite hesitant before traveling. But the way entire journey has been planned, charted out and facilitated by Gaf was truly exceptional. Dr. Ritu in Max has treated me well. My eye surgery went well.
★★★★★
Very nice hospitality, I have taken my mother to Fortis Hospital with help of Gaf healthcare. Initially, I was anxious but these guys made me very comfortable and mama got treated well. Thank you so much guys.
